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In this study, we aimed to investigate the aberrant expression and shift in localization of prohibitin
(PHB) during apoptosis of human cholangiocarcinoma cells. Our study demonstrated that PHB was
expressed primarily in the cytoplasm and only a little in the nucleus. However, PHB expression sig-
niﬁcantly decreased, and its localization shifted from the cytoplasm to the nucleus during apoptosis.
PHB co-localized with AIF, Rb, p53, and c-Fos, but the region of co-localization was altered after
treatment. Meanwhile, we detected a direct interaction between PHB and both p53 and Rb in
Mz-ChA-1 cells. These results suggest that the altered localization and expression of PHB, as well
as its co-localization with related oncogenes and tumor suppressor genes, can affect the apoptosis
of Mz-ChA-1 cells.
Structured summary of protein interactions:
AIF and PHB colocalize by ﬂuorescence microscopy (View interaction)
Rb and PHB colocalize by ﬂuorescence microscopy (View interaction)
c-Fos and PHB colocalize by ﬂuorescence microscopy (View interaction)
PHB and p53 colocalize by ﬂuorescence microscopy (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction The prohibitins form a high molecular weight complex in theProhibitins (PHB1 and PHB2), referred to here as PHB proteins,
are evolutionarily strongly conserved proteins that are present in
mitochondria of yeast, plants, and mammals [1–3]. PHB, as also
known PHB1, it has been functionally linked to diverse processes,
such as transcriptional regulation, cell proliferation, development,
and mitochondrial function [4–6]. It was shown that PHB might be
closely related with the development of cancer. The expression of
PHB was clearly upregulated in gastric cancer, liver cancer, and
uterine cancer. Another study demonstrated that over-expression
of PHB inhibited proliferation of MCF cells during vitamin D – in-
duced anti-proliferative activity and that PHB promoted apoptosis
via interaction with tumor suppressor proteins [7–10]. Therefore,
the roles of PHB in carcinogenesis and tumor cell reversal are still
unclear.mitochondrial inner membrane, and this complex has been shown
to have a role in the stabilization of newly synthesized subunits of
mitochondrial respiratory enzymes [2]. PHB is essential for normal
mitochondrial development, and PHB deﬁciency in Caenorhabditis
elegans is associated with deﬁcient mitochondrial biogenesis [11].
PHB is also localized to the plasma membrane in certain cell types,
and two recent reports suggest that it might function as a surface-
binding site [12,13]. Therefore, the function of PHB depends on its
localization in different tumor cell lines.
In previous study, we have demonstrated that apoptosis in hu-
man cholangiocarcinoma (Mz-ChA-1) [14], human cholangiocarci-
noma (QBC-939) [15] and human hepatocarcinoma (SMMC-7721)
[16] cells can be induced effectively using the novel inducer ESC-
3, the active ingredient of crocodile bile. Hereby, based on the
inducive effects of ESC-3 on the apoptosis of different human can-
cer cell lines, we extended our study to examine the aberrant
expression of PHB in ESC-3-treated human cholangiocarcinoma
Mz-ChA-1 cells. We aimed to investigate the localization shift of
PHB in Mz-ChA-1 cells, and ultimately, we explored the relation-
ship of PHB with related oncogenes and tumor suppressor genes.
This study aimed to provide additional evidence of the roles of
PHB in tumor cell apoptosis.
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2.1. Cell culture and treatment
Mz-ChA-1 cells, obtained from China Center for Type Culture
Collection, were maintained in RPMI-1640 medium supplemented
with 10% heat-inactivated fetal calf serum, 100 U/ml penicillin, and
100 lg/ml streptomycin at 37 C in a humidiﬁed atmosphere con-
taining 50 ml/l CO2. Twenty-four hours after seeding, the cells
were treated with culture medium containing 20 lg/ml ESC-3.
ESC-3 was a mixture of bile acids isolated from crocodile bile using
Sephadex LH-20 and RP-18 reversed-phase columns as described
in our previous study [14].
2.2. Two-dimensional gel electrophoresis and image analysis
2-D polyacrylamide gel electrophoresis (PAGE) was performed
as follows [17]. Immobilized linear pH 3–10 gradient 18 cm dry
strips (Bio-Rad, USA) were used for ﬁrst-dimension isoelectric
focusing. For the second dimension, 12% SDS–polyacrylamide gels
were used. The gels were stained using a silver nitrate solution
compatible with MS. Image scanning (UMAX Power Look III) and
analyses (PD Quest 8.0 software, Bio-Rad) of the three triplicate
sets of silver-stained 2D gels were performed. The digitized two-
dimensional electrophoresis (2-DE) gel images were compared
via the matching method. Differentially expressed spots were
annotated and analyzed.
These spots were cut from the gels. After a series of steps,
including silver removal, reduction with DL-dithiothreitol, alkyl-
ation with iodoacetamide, and in-gel digestion with trypsin, pep-
tide mass ﬁngerprints (PMFs) were generated using a Bruker III
MALDI-TOF mass spectrometer. The spectra were internally cali-
brated using the trypsin autolysis products [842.51 (M+H) and
2211.11 (M+H)] using Flex Analysis software and were searched
against the Swiss-Prot and NCBI databases using the Mascot tool
from matrix science. All of the searches were analyzed with a
50 ppm mass tolerance.
2.3. Western blot
Western blot analysis was performed as previously described
[14]. Brieﬂy, 20 lg cell lysates were loaded and separated on poly-
acrylamide gels and then transferred onto PVDF membranes (Mil-
lipore, Bedford, MA) according to a standard protocol. Non-speciﬁc
reactivity was blocked by incubating the membranes at 48 C for
1 h in PBS with 2% BSA. The target proteins were probed using pri-
mary antibodies and horseradish peroxidase-labeled secondary
antibodies (Santa Cruz). Immunoreactive proteins were detected
via an enhanced chemiluminescence (ECL) detection system
(Pierce). b-Actin was used as an indicator of equal lane loading.
2.4. RNA extraction and quantitative real-time PCR
These studies were performed as previously described [15].
Brieﬂy, total RNA was extracted from cells using the RNAiso Plus
Kit (Takara, Japan) following the manufacturer’s instructions. The
mRNA level of PHB was determined via quantitative real-time
PCR. The primers used for real-time PCR were as follows: 50-GCAG
GACATTGTGGTAGGGG-30 and 50-GCTGGTGAAGATGCGAGGAA-30
for the forward and reverse primers, respectively. Real-time quan-
titative PCR was performed using a SYBR PrimeScript RT-PCR Kit in
accordance with the manufacturer’s instructions. Then, PCR was
using a Rotor-Gene 6000 PCR cycler (Corbett Research, Australia)
according to the following protocol: 30 s at 95 C, one cycle; 10 s
at 95 C and 40 s at 57 C, 45 cycles. Fluorescence was detectedat the annealing stage of each cycle. A melting curve was generated
during the reactions to measure the occurrence of primer–dimer
formation. The 2DDCt method was used to calculate the relative
mRNA level of each gene.
2.5. Sample preparation for immunoﬂuorescence microscopy
After pre-ﬁxation with 4% paraformaldehyde at room tempera-
ture for 10 min, non-speciﬁc reactivity was blocked by incubating
the membranes at room temperature for 1 h in 3% BSA. The cover
slips were incubated with PHB primary antibodies at 37 C for
1 h. After washing, the cover slips were rinsed in tetramethylrhod-
amine isothiocyanate (TRITC) ﬂuorescent dye-labeled secondary
antibodies for 1 h at room temperature. Each cover slip was
mounted using one drop of anti-ﬂuorescence quencher. After-
wards, the cover slips were enveloped using 90% glycerol and ob-
served under a ﬂuorescence microscope.
2.6. Laser scanning confocal microscopic observation of PHB
These studies were performed as previously described [18]. Mz-
ChA-1 cells and ESC-3-treated cells were seeded on a cover slip and
cultured overnight. After washing twice with PBS for 10 min, the
cells were immersed in 0.5% Triton X-100 for 5–10 min. After ﬁxa-
tion with 4% paraformaldehyde for 10 min, the cells were blocked
with 3% BSA for 1 h. The cover slips were incubated with different
primary antibody mixtures (PHB/AIF, PHB/c-Fos, PHB/p53, or PHB/
Rb) at 4 C overnight. After washing, the cover slips were incubated
with secondary antibodies (labeled with ﬂuorescein) at 4 C for 3 h.
After sealing with an anti-ﬂuorescence quencher, the cover slip
was observed under a laser scanning confocal microscope (TCS-
SP2 MP). The negative control group was incubated with 3% BSA in-
stead of the primary antibody.
2.7. GST pull-down
The samples were incubated with non-carrier bacterial plas-
mids, and the constructed prokaryotic expressive strains were in-
duced by soluble expression. The GST protein and the GST
combined protein were reﬁned using glutathione sepharose 4B fol-
lowing the procedure described below. RIPA lysis buffer was used
to dissolve the Mz-ChA-1 cells, which were then centrifuged at
12000g at 4 C for 5 min. The centrifuged cell lysates were incu-
bated with GST and GST-PHB combined with beads at 4 C for 1 h
in a silent mixer. Next, they were washed three times using GST
washing buffer; 5  SDS loading buffer was added to perform
SDS-PAGE, and the same volume was added to the cell lysates as
described previously. The interaction between the prey protein
and the bait protein was veriﬁed by Western blot.
3. Results
3.1. Proteomic analysis of MZ-CHA-1 cells before and after treatment
For proteomic analysis, cell lysates from control and treated
cells were subjected to 2D-PAGE. The experiments were indepen-
dently repeated three times, and representative gel images are
shown in Fig. 1A. Scanned gels were quantiﬁed using PDQuest
8.0 version (Bio-Rad). Fig. 1B displays the enlarged maps of altered
expression of whole cell proteins from Mz-ChA-1 cells. We de-
tected approximately 292 ± 12 proteins spots on the silver-stained
gels of the control group, while 310 ± 10 protein spots were de-
tected on the gels of treated group, suggesting that the result of
2-DE PAGE was highly stable and reproducible. Each differentially
expressed protein spot was analyzed by MALDI–TOF–MS, and the
Fig. 1. Two-dimensional protein proﬁles fromMz-ChA-1 cells. (A) Representative two-dimensional protein proﬁles from the whole cell proteins of Mz-ChA-1 cells before and
after ESC-3 treatment. Proteins were separated on the basis of pI (X-axis) and molecular mass (Y-axis), and visualized by silver staining. The differentially expressed proteins
are marked with arrow symbols on the gels. Spots L1–L6 indicate the up-regulated proteins, while spots L7–L13 indicate the down-regulated proteins; L10 indicates the spot
of PHB. (B) Enlarged portions from 2-DE gels. (C) Optical density changes in the identiﬁed PHB protein spot in the control and treated Mz-ChA-1 cells. Three repeated sets of
silver-stained 2D gels were tested for each sample using PD Quest 8.0 software (P < 0.01).
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peptide library data (www.matrixscience.com). The identiﬁed pro-
teins are listed in Table 1. The expressions of human ERp44, Ran-
speciﬁc GTPase-activating protein, proteasome activator complex
subunit 1 isoform 1, and human galectin-1 were up-regulated,
while the expressions of Rho GDP dissociation inhibitor, tumor
protein translationally controlled 1, heterogeneous nuclear ribonu-
cleoprotein K, prohibitin, human heart L-lactate dehydrogenase H
chain, leukocyte elastase inhibitor, and S-adenosylhomocysteine
hydrolase were down-regulated. Another 31 protein spots were
not identiﬁed due to their low abundance. The spot encoded L10Table 1
The differential proteins identiﬁed by PMF searching against SwissProt Database.
Spot No. Protein name Acc
Up-regulated proteins
1 Chain A, crystal structure of human Erp44 gi|1
2 Ran-speciﬁc GTPase-activating protein gi|4
3 Unnamed protein product gi|1
4 Proteasome activator complex subunit 1 isoform 1 gi|5
5 Chain B, X-ray crystal structure of human galectin-1 gi|4
6 Ran-speciﬁc GTPase-activating protein gi|5
Down-regulated proteins
7 Rho GDP dissociation inhibitor gi|4
8 Tumor protein translationally controlled 1 gi|1
9 Heterogeneous nuclear ribonucleoprotein K gi|5
10 Prohibitin gi|4
11 Human heart L-lactate
Dehydrogenase Chain H
gi|1
12 Leukocyte elastase inhibitor gi|1
13 S-adenosylhomocysteine hydrolase gi|1was identiﬁed as PHB (Fig. 1B; Table 1), and the expression of
PHB was found to be reduced in the treated cells (Fig. 1C).
3.2. Conﬁrmation of altered expression of PHB
To further verify the aberrant change in PHB expression,Western
blot analysis and real-time PCR were employed to conﬁrm the pro-
tein and mRNA expression levels, respectively, of PHB in Mz-ChA-1
cells before and after treatment. TheWestern blot assay results pri-
marily indicated that the level of PHB in the treated cells was much
lower than the level of PHB in the control cells, suggesting that theession No. Protein MW(Da) Protein pI Protein score
93885198 44284 5.04 112
506407 23467 5.19 130
89053448 48541 5.52 138
453990 28876 5.78 99
2542978 15048 5.34 136
42991 23610 5.21 40
757768 23250 5.02 144
5214610 19759 4.84 66
5958547 42009 5.43 117
505773 29843 5.57 311
3786847 36769 5.72 122
3489087 42829 5.9 269
78277 48254 6.03 216
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by ESC-3 (Fig. 2A). Meanwhile, the results of real-time PCR revealed
that PHBwas also down-regulated after treatment, which is consis-
tent with the change in protein expression (Fig. 2B).
3.3. The localization and expression of PHB in MZ-CHA-1 cells
PHB in Mz-ChA-1 cells before and after treatment was labeled
with the ﬂuorescent dye TRITC, which ﬂuoresces red under a ﬂuo-
rescence microscope. The nuclei, which were stained with DAPI,
were blue in both the control and treated groups. As shown in
Fig. 2C, the intensity of red ﬂuorescence of human cholangiocarci-
noma Mz-ChA-1 cells was strong and distributed in the cytoplasm
and throughout the region of the karyoplasm and around the nu-
cleus. The red ﬂuorescence was stronger in the cytoplasm than in
the nucleus. After treatment, the density and distribution of red
ﬂuorescence, representing PHB expression, were both altered in
the nucleus. The density of red ﬂuorescence was weaker in the
cytoplasm and stronger in the nucleus, suggesting that the distri-
bution of PHB was shifted from the cytoplasmic compartment to
the nucleus.
3.4. The co-localization and interaction of PHB with AIF, p53, Rb, and
c-Fos
Mz-ChA-1 cells were double-immunolabeled using primary
antibodies for PHB and either AIF, Rb, p53, or c-Fos. The secondaryFig. 2. Expression and localization of PHB in Mz-ChA-1 cells before and after ECS-3 trea
decreased expression of PHB via ECS-3 treatment. The induction conditions used in this s
Localization of PHB observed under a ﬂuorescence microscope. PHB was labeled with TRI
DAPI were blue in both the control and treated groups. The distribution of PHB translocantibody against PHB was labeled with TRITC, which emitted red
ﬂuorescence; the secondary antibodies against the other proteins
were labeled with FITC, which emitted green ﬂuorescence. We em-
ployed laser confocal scanning microscopy to detect the changes in
co-localization of PHB with related gene products. The regions co-
localization appeared as yellow or orange-yellow.
In the control cells, the green ﬂuorescence representing AIF
was primarily distributed throughout the cell, but was more in-
tense in the cytoplasm than in the nucleus, although the density
was not uniform. In the nucleus, only slight scattered green ﬂuo-
rescence was detected. The results of merged ﬂuorescence
revealed that PHB co-localized with AIF near the nuclear mem-
brane (Fig. 3A–C). After treatment, the green ﬂuorescence of AIF
was greatly enhanced and uniformly distributed in the nucleus.
The merged ﬂuorescence revealed that the co-localization of
PHB with AIF was clearly present in the nucleus but not in the
cytoplasm, suggesting that the co-localization between PHB and
AIF disappeared from the cytoplasm adjacent to the nuclear
membrane (Fig. 3D–F).
In the control cells, the green ﬂuorescence representing p53
was very weak in nucleus and was primarily distributed in the
cytoplasm, especially near the nuclear membrane. The yellow
merged ﬂuorescence indicated that PHB clearly co-localized with
p53 in the nuclear membrane region (Fig. 3G–I). After ESC-3 treat-
ment, the green color was enhanced and was scattered in the
nucleus. The merged ﬂuorescence suggested that the region of
co-localization between PHB and p53 was clearly in the nucleustment. (A and B) Western blot and RT-PCR assays conﬁrmed the presence and the
tudy are consistent with previous study [14]. Actin was used as internal control. (C)
TC, which appeared as red under the ﬂuorescence microscope. The nuclei stained by
ated from the cytoplasm to the nucleus.
Fig. 3. Cellular co-localization of PHB with several oncogenes and tumor suppressor genes. (A–F) Expression of PHB and AIF in MZ-CHA-1 cells. The yellow ﬂuorescence in the
overlay indicates the co-localization between PHB and AIF. (G–L) Expression of PHB and p53 in MZ-CHA-1 cells. The yellow ﬂuorescence in the overlay indicates the co-
localization between PHB and p53. (M–R) Expression of PHB and Rb in MZ-CHA-1 cells. The yellow ﬂuorescence in the overlay indicates the co-localization between PHB and
Rb. (S–X) Expression of PHB and c-Fos in MZ-CHA-1 cells. The yellow ﬂuorescence in the overlay indicates the co-localization between PHB and c-Fos.
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membrane (Fig. 3J–L).
In the control cells, the FITC-labeled Rb emitting green ﬂuores-
cence was primarily distributed in the cytoplasm. The density of
the ﬂuorescence at the periphery of the nucleus was relatively
stronger, while the ﬂuorescence within the nucleus was weaker.
The merged yellow ﬂuorescence revealed that PHB co-localized
with Rb in the cytoplasmic compartment, especially near the nu-
cleus (Fig. 3M–O). After ESC-3 treatment, the green Rb ﬂuorescence
was enhanced and primarily distributed in the nucleus but had
weakened in the cytoplasm. The orange ﬂuorescence appeared in
the nucleus, suggesting that the co-localization of PHB with Rb
shifted from the cytoplasm to the nucleus (Fig. 3P–R).
In the control cells, according to the results of the ﬂuorescence
staining, the green ﬂuorescence representing c-Fos expression was
well-distributed throughout the cytoplasm. In the nucleus, only
slight scattered green ﬂuorescence was observed. The result ofmerged ﬂuorescence revealed that PHB co-localized with c-Fos in
the cytoplasm, especially near the nuclear membrane (Fig. 3S–U).
After treatment with ESC-3, the green c-Fos ﬂuorescence was
greatly decreased in the cytoplasm and was primarily localized
to the nucleus. The merged yellow ﬂuorescence suggested that
the co-localization of PHB with c-Fos decreased in the cytoplasm
and increased in the nucleus, indicating that the co-localization
of PHB with c-Fos shifted from the cytoplasm to the nucleus
(Fig. 3V–X).
3.5. The interaction between PHB and AIF, p53, Rb, and c-Fos in vitro
To further verify the interaction between PHB and these onco-
gene proteins in vitro, a GST pull-down assay was employed. Both
GST-PHB and GST were expressed in bacterial strain BL21 and were
puriﬁed to near homogeneity via GST afﬁnity chromatography
(Fig. 4A and B). As shown in Fig. 4C, after the recombinant proteins
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tant, the Western blot results indicated that direct interactions ex-
isted between GST-PHB and p53 in vitro, but no interaction existed
between GST and p53. Identical results appeared between GST-
PHB and Rb, but no signiﬁcant interaction was detected between
GST-PHB and either AIF or c-Fos (data not shown). According to
these results, we inferred that there is a direct interaction between
PHB and both p53 and Rb, which was consistent with the co-local-
ization results in Mz-ChA-1 cells.
4. Discussion
The alteration of cellular components is closely related to cell
carcinogenesis [19,20]. To further investigate the effects of apopto-
sis inducer ESC-3 on the protein expression of human cholangio-
carcinoma cancer cells, proteomic analysis was employed to
screen for the aberrant proteins of human cholangiocarcinoma
cells before and after treatment.
Our study demonstrated the existence and differential expres-
sion of PHB in Mz-ChA-1 cells after ESC-3 treatment. The expres-
sion of PHB was dramatically down-regulated in ESC-3 treated
cells. Changes in the protein expression level were conﬁrmed via
Western blot and RT-PCR assays.
Despite the evidence that PHB has anti-tumorigenic properties,
there are also a number of studies indicating a pro-tumorigenic
role of PHB. The role of PHB in cancer cell proliferation and/or
tumor suppression remains controversial [21]. Our results showed
that PHB was down-regulated during apoptosis of Mz-ChA-1 cells,
which suggested that PHB may be pro-tumorigenic rather than a
tumor suppressor. Here, we postulated that PHB might bi-
directionally regulate proliferation and apoptosis in different cell
lines and apoptosis stages. The change in PHB expression andFig. 4. The interactions between PHB and both p53 and Rb in vitro. (A) Expression of GST-
Puriﬁcation of PHB using GST afﬁnity chromatography (Amersham Biosciences) follow
Biosciences). (C) GST pull-down assay was employed to verify the interaction between PH
resolved via SDS–polyacrylamide gel electrophoresis and detected via Western blot.subcellular localization suggested that prohibitin might be a target
protein of ESC-3 which participated in the regulation of apoptosis
of Mz-ChA-1 cells.
PHB was primarily expressed in the cytoplasm but only a little
in the nucleus. A clear translocation from the cytoplasm to the nu-
cleus was observed. Our data primarily illustrated the subcellular
distribution of PHB. These results suggest that the alteration of
expression and subcellular distribution are closely related to the
process of apoptosis in Mz-ChA-1 cells. As an important differen-
tially expressed protein, PHB might play pivotal roles in the regu-
lation of human cholangiocarcinoma Mz-ChA-1 cell apoptosis. The
involvement of PHB in essential biological processes, such as
metabolism, cell proliferation, and development, implicates a crit-
ical pleiotropic role for PHB. In this study, we revealed that there
was co-localization between PHB and c-Fos, Rb, p53, and AIF in
Mz-ChA-1 cells that were altered with treatment, as measured by
immunoﬂuorescence microscopy and laser scanning confocal
microscopy.
During apoptosis, AIF is released from the mitochondrial inter-
membrane space to the cytosol and the nucleus [22]. PHB plays a
critical role in maintaining normal mitochondrial function and
morphology [21]. Therefore, we postulated that a close relation-
ship could occur between PHB and AIF during apoptosis of Mz-
ChA-1 cells. In our study, the co-localization between PHB and
AIF disappeared from the cytoplasm near the nuclear membrane
after treatment. For the ﬁrst time, our study presented the co-local-
ization of PHB with AIF, suggesting PHB mediates the apoptosis of
cholangiocarcinoma Mz-ChA-1 cells via AIF release from mito-
chondria to the nucleus.
PHB has also been shown to interact with the retinoblastoma
tumor suppressor protein (Rb) and its family members, p107 and
p130, in the nucleus [23]. The Rb family suppresses growth viaPHB in E. coli strain BL21 induced by IPTG. Ovals indicate GST-PHB protein bands. (B)
ed by size exclusion chromatography using a Superdex 200 column (Amersham
B and both p53 and Rb in MZ-CHA-1 cells in vitro. Speciﬁcally bound proteins were
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[24]. PHB was shown to repress E2F-mediated transcription via
its interaction with Rb and histone deacetylase [25]. In our study,
we found that the region of co-localization between PHB and p53
was clearly in the nucleus and moderately decreased in the cyto-
plasm near the nuclear membrane after treatment with ESC-3.
Obviously, this alteration is correlated with the proliferation and
apoptosis of Mz-ChA-1 cells because the region of the nuclear lam-
ina is an active site of DNA replication and transcription; this syn-
ergistic translocation of PHB and p53 may inﬂuence the expression
of p53 and its downstream genes in Mz-ChA-1 cells, resulting in tu-
mor cell reversion. Similarly, co-localization between PHB and Rb
was present in the cytoplasmic region, especially near the nucleus.
However, we also observed that the co-localization of PHB and Rb
translocated from the cytoplasm to the nucleus after treatment.
The interaction between PHB and both p53 and Rb were further
veriﬁed via the GST pull-down experiment. This phenomenon
illustrates that the alteration of PHB trafﬁcking and its enhanced
co-localization with Rb in the nucleus may repress the ability of
E2F to activate the expression of its downstream genes, subse-
quently controlling cell proliferation and promoting apoptosis.
Previous studies showed that PHB and c-Fos were regulated by
Rb, and the expression of PHB and c-Fos was increased in cells in
which Rb was over-expressed [26,27]. The co-localization between
PHB and Rb was mentioned above; we observed that there was dis-
tinct co-localization between PHB and c-Fos in the nucleus. These
results bring are consistent with the altered region of co-localiza-
tion between PHB and Rb, indicating that c-Fos and Rb preceded
the process of regulation of apoptosis in Mz-ChA-1 cells after
ESC-3 treatment. However, these results were not veriﬁed in our
GST pull-down experiment. Therefore, further research on the c-
Fos protein is needed, as we could not ﬁnd published research on
the interaction between PHB and c-Fos in apoptotic cells.
Our study primarily analyzed and revealed the aberrant loca-
tion and expression of PHB in ESC-3-induced apoptosis of Mz-
ChA-1 cells, as well as the interaction of PHB with oncogenes and
tumor suppressor genes. Our ﬁndings will help to elucidate the
function of PHB during apoptosis of Mz-ChA-1 cells, and the rela-
tionships between PHB and tumor related genes have offered
new insight into the mechanism of apoptosis of human cholangio-
carcinoma cells.
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